January 2010 Contents
Cover Story
Digital Pathology and Biomarkers Help Pave the Way to Personalized Medicine
Christopher Ung, VP, Strategic Business & Operations, Oncology, Quintiles
Advances in biomarker technology are aiding researchers in identifying the right treatments - for the right patient.
Drug Manufacturing
Planning for Success
Pedram Alaedini, President and CEO, Primapax Biopharma
A pathway to obtaining US FDA approval for developing, manufacturing and commercializing generic drugs.
A Workflow Approach
Robert Plumb, Michael Jones, Marian Twohig, Karen Haas, Waters Corporation
Mass Spectrometry and its related technologies offer accuracy and efficiency in the identification and structural elucidation of impurities in a drug substance.
Drug Delivery
Inhaled Drug Delivery: Market Opinion
Georgina Fradley; Louise Righton; Yuan Lu Ho, 3M Drug Delivery Systems
Drug delivery innovators are designing inhalation devices based on the demands of regulatory authorities and consumers.
Editor''s Note
A Fresh Start
Michael Tham, Editor
Global News
Pfizer and Strides Arcolab to Collaborate on Generic Products
Artes and Rhein Minapharm Continue Joint Product Development
PPD Selected as Exclusive Partner by DiabetesAmerica
OncoMed Pharmaceuticals and Fluidigm Corporation Announce Collaboration
Regional News
Tianyin Pharmaceutical Receives Approval from SFDA
Sinovac Files Clinical Trial Application for HFMD in China
Vaccines: Big Players Push into Asia
Drug Discovery
Mass Spectrometry: Processing Power
John Moncur, director SpectralWorks
Rapid advancements are pushing the technology towards higher productivity and greater precision.
Drug Development
On the Move: Pharmaceuticals R&D in Asia (Part Four)
Frank Floether, VP business development Asia Pacific (2004-2008), Johnson & Johnson
Different countries posses varying characteristics that affect the selection of business models for outsourcing activities.
Special Report
Pharma Outlook 2010
With the economic landscape starting to look rosier as countries recover from the global recession, experts share their views on industry trends and developments for the year ahead.
Clinical Trials
Facilitating Data Management in Clinical Trials
Nick Giannasi, VP of Strategy, Oracle Health Sciences; Yashi Kant, VP, Oracle Health Sciences, APAC
Organizations are harnessing technologies such as Electronic Data Capture (EDC) to improve the efficiency of clinical studies.
Product Focus
PBL InterferonSource Introduces Multiplex ELISA Arrays
KD Scientific Offers Programmable Syringe Pumps
Wyatt Technology Launches Size Exclusion Chromatography Columns
Integra: Safe Vacuum Disposal of Liquids
